2013
DOI: 10.1016/b978-0-12-407703-4.00002-5
|View full text |Cite
|
Sign up to set email alerts
|

Stakeholder Views on Returning Research Results

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 176 publications
1
12
0
Order By: Relevance
“…This supports findings that research participants often feel that participation in a biobank should be mutually beneficial and express interest in receiving personally relevant clinically significant results ( i.e. , actionable results) [ 35 , 36 , 37 , 38 ]. Returning such results, however, also have the potential to do harm for reasons such as difficulties in understanding genetic risk information [ 39 ], the uncertain actionability of some genetic research findings, and the radical actions some participants may take with genetic research findings due to their anxieties and fears.…”
Section: Discussionsupporting
confidence: 77%
“…This supports findings that research participants often feel that participation in a biobank should be mutually beneficial and express interest in receiving personally relevant clinically significant results ( i.e. , actionable results) [ 35 , 36 , 37 , 38 ]. Returning such results, however, also have the potential to do harm for reasons such as difficulties in understanding genetic risk information [ 39 ], the uncertain actionability of some genetic research findings, and the radical actions some participants may take with genetic research findings due to their anxieties and fears.…”
Section: Discussionsupporting
confidence: 77%
“…Previous studies largely focused on understanding the perspectives of research participants and patients related to genetic and genomic testing in the context of their ethical, legal, policy, and social implications (ELSI). Surveys, interviews, and focus groups reveal several lingering concerns, such as (1) who will have access to genetic test information, especially when the information is in electronic medical records (Beskow and Dean 2008 ; Hull et al 2008 ; Kettis-Lindblad et al 2006 ; McGuire et al 2008 ; Trinidad et al 2010 ), (2) will genetic research data be shared with outside investigators (Abraham et al 2014 ; Kaufman et al 2009 ; Ludman et al 2010 ; Rahm et al 2013 ), and (3) will individuals have access to their own genetic research data (Godard et al 2007 ; Haga and Zhao 2013 ; Ormond et al 2009 ). These studies suggest that privacy and confidentiality are particularly important in the context of discrimination by insurers and employers who may have access to genetic information (Wong et al 2004 ).…”
Section: Introductionmentioning
confidence: 99%
“…There is an emerging consensus in the ethics literature 24,29,30,31,31 and professional guidelines that all data that are believed to be clinically ‘actionable’ should be fed back to patients or participants. This consensus is supported by empirical data showing that most people wish to receive information about those data whether it concerns the condition under investigation or an unexpected, incidental secondary finding . In the context of reproductive medicine, however, the concept of ‘actionability’ is likely to prove contested and value‐laden.…”
Section: Ethical Issuesmentioning
confidence: 99%